Orrstown Financial Services (ORRF) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
Net income for Q2 2025 was $19.4M ($1.01 per diluted share), up 151.3% year-over-year and 7.7% sequentially; adjusted net income was $20.2M ($1.04), with merger-related expenses now largely complete.
Profitability metrics remain at the high end of the peer group, with strong GAAP and core earnings and no significant future merger costs anticipated.
Board declared a $0.27 per share dividend, a $0.01 increase, and authorized a repurchase program for up to 500,000 shares.
Tangible book value per share rose to $22.77 at June 30, 2025, from $21.99 at March 31, 2025.
Focus remains on reigniting earnings, improving efficiency, and maintaining strong credit quality.
Financial highlights
Net interest income for Q2 2025 was $49.5M; net interest margin improved to 4.07%, up 7 bps sequentially.
Noninterest income rose to $12.9M, up $1.3M from the prior quarter, driven by swap fees, treasury management, and mortgage banking income.
Noninterest expenses decreased by $0.6M to $37.6M, despite $1M in merger-related and $600K in severance costs.
Efficiency ratio improved to 60.3% (58.7% adjusted) from 63.2% (60.5% adjusted) in Q1 2025.
Loans increased by $55.4M (6% annualized) from Q1 2025; deposits decreased by $117.1M to $4.5B.
Outlook and guidance
Loan growth guidance for the remainder of 2025 is 5.0% annualized, with NIM expected in the range of 4.05% to 4.15%.
Fee income run rate expected around $12M per quarter; noninterest expenses: $140M–$145M annualized.
Expense run rate anticipated at $35–36M per quarter, with efficiency ratio approaching 55% early next year.
Effective tax rate projected at approximately 21%, assuming stable economic conditions.
NIM projected to have further upside in Q3, stabilizing thereafter if rates remain unchanged; rate cuts could pressure NIM.
Latest events from Orrstown Financial Services
- Record earnings, strong loan growth, and higher dividend highlight robust 2025 results.ORRF
Q4 20253 Feb 2026 - Shelf registration allows up to $200M in securities for flexible corporate funding and growth.ORRF
Registration Filing29 Jan 2026 - Q1 2025 net income and EPS surged, with strong capital and lower merger costs.ORRF
Q1 202523 Dec 2025 - Major merger, robust financials, and key governance votes highlight this year's proxy.ORRF
Proxy Filing2 Dec 2025 - Q3 2025 net income hit $21.9M, with record margins, strong growth, and robust capital.ORRF
Q3 20256 Nov 2025 - Q3 2024 loss from merger costs offset by strong adjusted earnings and loan growth.ORRF
Q3 202413 Jun 2025 - Q2 net income declined, but dividend rose 15% and Codorus merger integration is on track.ORRF
Q2 202413 Jun 2025 - Q4 2024 net income rebounded, merger integration completed, and cost savings achieved.ORRF
Q4 20245 Jun 2025